PharmGen Science Inc Cash Flow Conversion Efficiency

Latest as of September 2025: 0.008x

PharmGen Science Inc cash flow conversion efficiency. Based on the latest financial reports, PharmGen Science Inc (004720) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.91 Billion ≈ $1.29 Million USD) by net assets (₩247.76 Billion ≈ $167.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of PharmGen Science Inc (2011–2024)

Cash flow conversion efficiency of PharmGen Science Inc from 2011 to 2024. This chart illustrates how PharmGen Science Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest PharmGen Science Inc stock price today for real-time trading data and today's change.

PharmGen Science Inc Cash Flow Conversion Ratio Explained

PharmGen Science Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

PharmGen Science Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PharmGen Science Inc ranked by their cash flow conversion efficiency. Also see PharmGen Science Inc (004720) total market value for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Batm Advanced Communications Ltd TA:BVC	0.015x
Cyan AG XETRA:CYR	0.008x
IGLOO SECURITY Inc KQ:067920	-0.005x
Surapon Foods Public Company Limited BK:SSF	0.082x
CTI Traffic Industries Co Ltd TWO:2230	-0.134x
Dae Hyun KO:016090	0.028x
Sportsmans NASDAQ:SPWH	0.078x
Wha Yu Industrial Co Ltd TW:3419	-0.083x

Annual Cash Flow Conversion Efficiency for PharmGen Science Inc (2011–2024)

The table below shows the annual cash flow conversion efficiency of PharmGen Science Inc from 2011 to 2024. Review PharmGen Science Inc (004720) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩249.43 Billion ≈ $169.03 Million	₩2.38 Billion ≈ $1.62 Million	0.010x	-59.89%
2023-12-31	₩228.21 Billion ≈ $154.66 Million	₩5.44 Billion ≈ $3.69 Million	0.024x	+483.79%
2022-12-31	₩207.12 Billion ≈ $140.36 Million	₩-1.29 Billion ≈ $-871.62K	-0.006x	-110.13%
2021-12-31	₩126.93 Billion ≈ $86.02 Million	₩7.78 Billion ≈ $5.28 Million	0.061x	+91.54%
2020-12-31	₩83.57 Billion ≈ $56.63 Million	₩2.68 Billion ≈ $1.81 Million	0.032x	-28.64%
2019-12-31	₩56.25 Billion ≈ $38.12 Million	₩2.52 Billion ≈ $1.71 Million	0.045x	-39.50%
2018-12-31	₩56.85 Billion ≈ $38.52 Million	₩4.22 Billion ≈ $2.86 Million	0.074x	+106.01%
2017-12-31	₩51.05 Billion ≈ $34.60 Million	₩1.84 Billion ≈ $1.25 Million	0.036x	-83.10%
2016-12-31	₩36.41 Billion ≈ $24.67 Million	₩7.75 Billion ≈ $5.26 Million	0.213x	+68.55%
2015-12-31	₩28.66 Billion ≈ $19.42 Million	₩3.62 Billion ≈ $2.45 Million	0.126x	+226.04%
2014-12-31	₩20.12 Billion ≈ $13.63 Million	₩-2.02 Billion ≈ $-1.37 Million	-0.100x	+43.17%
2013-12-31	₩23.83 Billion ≈ $16.15 Million	₩-4.20 Billion ≈ $-2.85 Million	-0.176x	-213.97%
2011-12-31	₩18.69 Billion ≈ $12.67 Million	₩2.89 Billion ≈ $1.96 Million	0.155x	--

About PharmGen Science Inc

KO:004720 Korea Drug Manufacturers - General

Market Cap

$42.03 Million

₩62.01 Billion KRW

Market Cap Rank

#22355 Global

#1428 in Korea

Share Price

₩2830.00

Change (1 day)

+2.35%

52-Week Range

₩2710.00 - ₩4400.00

All Time High

₩27300.00